Vertex Pharmaceuticals, Inc. (VRTX)
449.53
-5.14
(-1.13%)
USD |
NASDAQ |
Jan 14, 16:00
449.50
-0.03
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals SG&A Expense (TTM): 1.644B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Amgen, Inc. | 6.976B |
| Eli Lilly & Co. | 10.39B |
| Merck & Co., Inc. | 10.70B |
| Regeneron Pharmaceuticals, Inc. | 2.717B |